Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Rentschler, a leading CMO for the development and production of biopharmaceuticals, has hosted its second Laupheimer Zelltage conference with the theme 'Bioprocess light' on June 11 and 12, 2012 in Laupheim, Germany. Over 190 leading scientists from ...
read more
Almac Group has reported an £85.4 million rise in turnover from £548.9 million to £634.3 million for its financial year 2018-19.
read more
Tuesday, January 06, 2015
3C! Packaging, an independent privately-owned pharmaceutical packaging solutions company specializing in the design and manufacture of custom folding cartons, printed literature, inserts/outserts, labels/foils and unit dose applications, will begin ...
read more
Thursday, February 19, 2015
3C! Packaging, an independent privately-owned pharmaceutical packaging solutions company specializing in the design and manufacture of custom folding cartons, printed literature, inserts/outserts, labels/foils and unit dose applications, will ...
read more
3P Biopharmaceuticals has signed a collaboration agreement with the Dutch biotech company Xenikos that will cover the global manufacturing of Xenikos’ proprietary lead product candidate T-Guard®.
read more
Thursday, December 27, 2018
3P Biopharmaceuticals has completed the project for the expansion and improvement of its facilities in Noáin (Spain) that had been carried out over the past months
read more
Friday, September 20, 2019
The FDA has classified 3P facilities as acceptable for the manufacture of the target molecule, and appropriate for its commercialization in the US market, once the product is authorized.
read more
Medical device manufacturers hoping to enter the US market face increasing commercial competition and challenges to gain the funding necessary to support emerging brands. Because development and commercialization can consume a lot of resources, many...
read more
Wednesday, December 01, 2021
AGC Biologics, a global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced a new partnership with 4TEEN4 Pharmaceuticals GmbH to manufacture and commercialize Procizumab. The first-in-class monoclonal antibody ...
read more
Tuesday, December 11, 2012
AAIPharma Services Corp. (“AAIPharma”), a leading provider of pharmaceutical product development services, announced today that it has appointed Timothy Rhines, Ph.D., RAC as the company’s senior director of biopharmaceutical development for its ...
read more
AAIPharma Services Corp. (“AAIPharma”), a leading provider of pharmaceutical product development services, announced today that it has appointed James Fife as the company’s senior director of parenteral operations for its manufacturing facility in ...
read more
Wednesday, December 04, 2013
AAIPharma Services, Corp. (“AAI”), a
leading global provider of pharmaceutical analytical testing, product development and
manufacturing services and Cambridge Major Laboratories, Inc. (“CML”), a global leader in
pharmaceutical API development and...
read more
Tuesday, January 28, 2014
AAIPharma Services Corp. (“AAIPharma”), a
leading global provider of pharmaceutical analytical testing, product development and
manufacturing services and Cambridge Major Laboratories, Inc. (“CML”), a global leader in
pharmaceutical API ...
read more
Thursday, February 06, 2014
AAIPharma Services Corp. (“AAIPharma”), a leading global provider of pharmaceutical analytical testing, product development and manufacturing services and Cambridge Major Laboratories, Inc. (“CML”), a global leader in pharmaceutical API development ...
read more
Friday, February 07, 2014
AAIPharma Services, Corp. (“AAIPharma”),
a leading global provider of pharmaceutical analytical testing, product development and
manufacturing services and Cambridge Major Laboratories, Inc (“CML”), a global leader in
pharmaceutical API ...
read more